SlideShare une entreprise Scribd logo
1  sur  8
FREQUENTLY ASKED QUESTIONS

   INFORMATION ON STEM CELLS
      FOR GENERAL AUDIENCE
WHAT IS STEM CELLS?

Stem cells are the foundation cells for every organ and tissue in our bodies. The
highly specialized cells that make up these tissues originally came from an initial pool
of stem cells formed shortly after fertilization.


Cell Life. Throughout our lives, we continue to rely on stem cells to replace injured
tissues and cells that are lost every day, such as those in our skin, hair, blood and the
lining of our gut.


Properties. Stem cells have two key properties:
1)   the ability to self-renew, dividing in a way that makes copies of themselves, and
2)   the ability to differentiate, giving rise to the mature types of cells that make up
     our organs and tissues
STEM CELLS TYPE

1.    Embryonic Stem Cells
Cells derived from very early in development, usually the inner cell mass of a developing
blastocyst (very early embrio). These cells are self-renewing (can replicate themselves) and
pluripotent (can form all cell types found in the body).


2.    Fetal Stem Cells
fetal stem cells are taken from the fetus. The developing baby is referred to as a fetus from
approximately 10 weeks of gestation. Most tissues in a fetus contain stem cells that drive the
rapid growth and development of the organs. Like adult stem cells, fetal stem cells are generally
tissue specific, and generate the mature cell types within the particular tissue or organ in which
they are found.


3.    Cord Blood Stem Cells
At birth the blood in the umbilical cord is rich in blood-forming stem cells. The applications of
cord blood are similar to those of adult bone marrow and are currently used to treat diseases and
conditions of the blood or to restore the blood system after treatment for specific cancers. Like
the stem cells in adult bone marrow, cord blood stem cells are tissue-specific.
STEM CELLS TYPE

4.    Adult Stem Cells or Tissue Specific Stem Cells
Stem cells found in different tissues of the body that can give rise to some or all of the mature
cell types found within the particular tissue or organ from which they came, i.e., blood stem cells
can give rise to all the cells that make up the blood, but not the cells of organs such as the liver or
brain.


5.   Mesenchymal Stem Cells
Mesenchymal stem cells were originally discovered in the bone marrow, but have since been
found throughout the body and can give rise to a large number of connective tissue types such as
bone, cartilage and fat.


6.    Induced Pluripotent Stem Cells (iPS cells)
stem cells that were from a cell with a specialized function (for example, a skin cell) that has been
“reprogrammed” to an unspecialized state similar to that of an embryonic stem cell.
WHAT IS STEM CELLS THERAPY

Therapy. A stem cell therapy is a treatment that uses:
     – Stem cells,
     – Protein secreted by stem cells , or
     – Cells that come from stem cells, to replace or to repair a patient’s cells or tissues that
       are damaged.


Application.      The stem cells might be put into the blood, or transplanted into the damaged
tissue directly, or even recruited from the patient’s own tissues for self-repair.
MEDICAL CLINIC

Clinical translation     is the process used to turn scientific knowledge into real world medical
treatments. Researchers take what they have learned about how a tissue usually works and what
goes wrong in a particular disease or injury and use this information to develop new ways to
diagnose, stop or fix what goes wrong.

Before being marketed or adopted as standard of care, most treatments are tested through
clinical trials. Sometimes, in attempting new surgical techniques or where the disease or
condition is rare and does not have a large enough group of people to form a clinical trial, certain
treatments might be tried on one or two people, a form of testing sometimes referred to as
innovative medicine.
POTENTIAL THERAPY

Blood stem cells       are currently the most frequently used stem cells for therapy. For more than 50
years, doctors have been using bone marrow transplants to transfer blood stem cells to patients, and
more advanced techniques for collecting blood stem cells are now being used to treat leukemia,
lymphoma and several inherited blood disorders.


Umbilical cord blood, like bone marrow, is often collected as a source of blood stem cells and in
certain cases is being used as an alternative to bone marrow transplantation. Additionally, some bone,
skin and corneal diseases or injuries can be treated by grafting tissues that are derived from or
maintained by stem cells. These therapies have also been shown to be safe and effective.


Mesenchymal stem cell, found              throughout the body including in the bone marrow, can be
directed to become bone, cartilage, fat and possibly even muscle. In certain experimental models, these
cells also have some ability to modify immune functions. These abilities have created considerable
interest in developing ways of using mesenchymal stem cells to treat a range of musculoskeletal
abnormalities, cardiac disease and some immune abnormalities such as graft-versus-host disease
following bone marrow transplant.
CHALLENGES
First, identifying, isolating and growing the right kind of stem cell, particularly in the case of rare
adult stem cells, are painstaking and difficult processes. Pluripotent stem cells, such as embryonic
stem cells, can be grown indefinitely in the lab and have the advantage of having the potential to
become any cell in the body, but these processes are again very complex and must be tightly
controlled. iPS cells, while promising, are also limited by these concerns. In both cases,
considerable work remains to be done to ensure that these cells can be isolated and used safely
and routinely.

Second,     as with organ transplants, it is very important to have a close match between the
donor tissue and the recipient. The more closely the tissue matches the recipient, the lower the
risk of rejection. Being able to avoid the lifelong use of immunosuppressants would also be
preferable. The discovery of iPS cells has opened the door to developing patient-specific
pluripotent stem cell lines that can later be developed into a needed cell type without the
problems of rejection and immunosuppression that occur from transplants from unrelated
donors.

Third, a system for delivering the cells to the right part of the body must be developed. Once in
the right location, the new cells must then be encouraged to integrate and function together with
the body’s other cells.

Contenu connexe

Tendances

Stem Cell Research
Stem Cell ResearchStem Cell Research
Stem Cell Researchjfreshour
 
Stem Cell
Stem CellStem Cell
Stem Celldanggo
 
Animal Stem Cell Therapy Presentation by MediVet Midwest
Animal Stem Cell Therapy Presentation by MediVet MidwestAnimal Stem Cell Therapy Presentation by MediVet Midwest
Animal Stem Cell Therapy Presentation by MediVet Midwestmedivetmidwest
 
Regenerative medicine
Regenerative medicineRegenerative medicine
Regenerative medicineLM9
 
Adipose Derived Stem cells in plastic surgery
Adipose Derived Stem cells in plastic surgeryAdipose Derived Stem cells in plastic surgery
Adipose Derived Stem cells in plastic surgeryAhmed Atef
 
Stem cell therapy
Stem cell therapyStem cell therapy
Stem cell therapyMika Ghosh
 
Stem Cell Research: Trends and Perspectives on the Evolving International Lan...
Stem Cell Research: Trends and Perspectives on the Evolving International Lan...Stem Cell Research: Trends and Perspectives on the Evolving International Lan...
Stem Cell Research: Trends and Perspectives on the Evolving International Lan...Elsevier
 
Stem cells
Stem cellsStem cells
Stem cellsDACB
 
Stem cell-therapy-for-cerebral-palsy
Stem cell-therapy-for-cerebral-palsyStem cell-therapy-for-cerebral-palsy
Stem cell-therapy-for-cerebral-palsyNeurogen
 
Adult stem cells emily block 3
Adult stem cells emily block 3Adult stem cells emily block 3
Adult stem cells emily block 315bateem
 

Tendances (20)

Stem Cell Research
Stem Cell ResearchStem Cell Research
Stem Cell Research
 
Stem cells & therapy(mutaib)
Stem cells & therapy(mutaib)Stem cells & therapy(mutaib)
Stem cells & therapy(mutaib)
 
Stem Cell
Stem CellStem Cell
Stem Cell
 
Adult Stem Cells
Adult Stem CellsAdult Stem Cells
Adult Stem Cells
 
#SciChallenge2017
#SciChallenge2017#SciChallenge2017
#SciChallenge2017
 
Animal Stem Cell Therapy Presentation by MediVet Midwest
Animal Stem Cell Therapy Presentation by MediVet MidwestAnimal Stem Cell Therapy Presentation by MediVet Midwest
Animal Stem Cell Therapy Presentation by MediVet Midwest
 
Regenerative medicine
Regenerative medicineRegenerative medicine
Regenerative medicine
 
Adipose Derived Stem cells in plastic surgery
Adipose Derived Stem cells in plastic surgeryAdipose Derived Stem cells in plastic surgery
Adipose Derived Stem cells in plastic surgery
 
Stem cell therapy
Stem cell therapyStem cell therapy
Stem cell therapy
 
Stem Cell Research: Trends and Perspectives on the Evolving International Lan...
Stem Cell Research: Trends and Perspectives on the Evolving International Lan...Stem Cell Research: Trends and Perspectives on the Evolving International Lan...
Stem Cell Research: Trends and Perspectives on the Evolving International Lan...
 
Stem cells background
Stem cells backgroundStem cells background
Stem cells background
 
Stem cells
Stem cellsStem cells
Stem cells
 
Stem cell-therapy-for-cerebral-palsy
Stem cell-therapy-for-cerebral-palsyStem cell-therapy-for-cerebral-palsy
Stem cell-therapy-for-cerebral-palsy
 
Recent trends in a treatment of diseases by using stem cells
Recent trends in a treatment of diseases by using stem cellsRecent trends in a treatment of diseases by using stem cells
Recent trends in a treatment of diseases by using stem cells
 
Stem Cell Migration
Stem Cell MigrationStem Cell Migration
Stem Cell Migration
 
Ethics/Biomedical Research Stem Cells
Ethics/Biomedical Research Stem CellsEthics/Biomedical Research Stem Cells
Ethics/Biomedical Research Stem Cells
 
Adult stem cells emily block 3
Adult stem cells emily block 3Adult stem cells emily block 3
Adult stem cells emily block 3
 
Stem cell
Stem cellStem cell
Stem cell
 
Adult stem cells hope
Adult stem cells hopeAdult stem cells hope
Adult stem cells hope
 
Stem cell
Stem cellStem cell
Stem cell
 

En vedette

Pycnogenol (french maritime pine bark extract)
Pycnogenol (french maritime pine bark extract)Pycnogenol (french maritime pine bark extract)
Pycnogenol (french maritime pine bark extract)raditio ghifiardi
 
Research progress by dr. Yuyun Rindiastuti
Research progress by dr. Yuyun RindiastutiResearch progress by dr. Yuyun Rindiastuti
Research progress by dr. Yuyun Rindiastutiraditio ghifiardi
 
Aplikasi Klinis Stem Cell by Dr. Indah Yulianto
Aplikasi Klinis Stem Cell by Dr. Indah YuliantoAplikasi Klinis Stem Cell by Dr. Indah Yulianto
Aplikasi Klinis Stem Cell by Dr. Indah Yuliantoraditio ghifiardi
 
Auto immune bulous pemphigoid Case Study
 Auto immune bulous pemphigoid Case Study Auto immune bulous pemphigoid Case Study
Auto immune bulous pemphigoid Case Studyraditio ghifiardi
 
Peranan telomer pada proses penuaan & keganasan akibat Distres
Peranan telomer pada proses penuaan & keganasan akibat DistresPeranan telomer pada proses penuaan & keganasan akibat Distres
Peranan telomer pada proses penuaan & keganasan akibat Distresraditio ghifiardi
 
Tribute lecture at Brawijaya Women & Children Hospital
Tribute lecture at Brawijaya Women & Children HospitalTribute lecture at Brawijaya Women & Children Hospital
Tribute lecture at Brawijaya Women & Children Hospitalraditio ghifiardi
 
Advances in Cancer Stem Cell Biology
Advances in Cancer Stem Cell BiologyAdvances in Cancer Stem Cell Biology
Advances in Cancer Stem Cell Biologyraditio ghifiardi
 
Allogeineic Stem Cell Transplantation for adult acute lymphoblastic leukemia:...
Allogeineic Stem Cell Transplantation for adult acute lymphoblastic leukemia:...Allogeineic Stem Cell Transplantation for adult acute lymphoblastic leukemia:...
Allogeineic Stem Cell Transplantation for adult acute lymphoblastic leukemia:...raditio ghifiardi
 
Sudut Pandang Moral - Immoral Terhadap Sel Punca by Prof. Dr. Soehartono Taa...
Sudut Pandang Moral - Immoral Terhadap Sel Punca  by Prof. Dr. Soehartono Taa...Sudut Pandang Moral - Immoral Terhadap Sel Punca  by Prof. Dr. Soehartono Taa...
Sudut Pandang Moral - Immoral Terhadap Sel Punca by Prof. Dr. Soehartono Taa...raditio ghifiardi
 
Wharton’s jelly mesenchymal stem cells as off the-shelf cellular therapeutics...
Wharton’s jelly mesenchymal stem cells as off the-shelf cellular therapeutics...Wharton’s jelly mesenchymal stem cells as off the-shelf cellular therapeutics...
Wharton’s jelly mesenchymal stem cells as off the-shelf cellular therapeutics...raditio ghifiardi
 
Dermama catalog corporate profile
Dermama   catalog corporate profileDermama   catalog corporate profile
Dermama catalog corporate profileraditio ghifiardi
 
Stem Cell Therapy & Other Recent Advances in Muscular dystrophy
Stem Cell Therapy & Other Recent Advances in Muscular dystrophyStem Cell Therapy & Other Recent Advances in Muscular dystrophy
Stem Cell Therapy & Other Recent Advances in Muscular dystrophyraditio ghifiardi
 
Treating Options for Acute lymphoblastic Leukemia
Treating Options for Acute lymphoblastic LeukemiaTreating Options for Acute lymphoblastic Leukemia
Treating Options for Acute lymphoblastic Leukemiaraditio ghifiardi
 
Conditioned medium – of adipocyte derived stem cells
Conditioned medium – of adipocyte derived stem cellsConditioned medium – of adipocyte derived stem cells
Conditioned medium – of adipocyte derived stem cellsraditio ghifiardi
 
Stem sel pada hewan dan aplikasinya
Stem sel pada hewan dan aplikasinyaStem sel pada hewan dan aplikasinya
Stem sel pada hewan dan aplikasinyaraditio ghifiardi
 
And iemerg 2014
And iemerg 2014And iemerg 2014
And iemerg 2014massican
 
Platelets rich plasma for skin rejuvenation
Platelets rich plasma for skin rejuvenationPlatelets rich plasma for skin rejuvenation
Platelets rich plasma for skin rejuvenationraditio ghifiardi
 

En vedette (19)

Pycnogenol (french maritime pine bark extract)
Pycnogenol (french maritime pine bark extract)Pycnogenol (french maritime pine bark extract)
Pycnogenol (french maritime pine bark extract)
 
Research progress by dr. Yuyun Rindiastuti
Research progress by dr. Yuyun RindiastutiResearch progress by dr. Yuyun Rindiastuti
Research progress by dr. Yuyun Rindiastuti
 
Aplikasi Klinis Stem Cell by Dr. Indah Yulianto
Aplikasi Klinis Stem Cell by Dr. Indah YuliantoAplikasi Klinis Stem Cell by Dr. Indah Yulianto
Aplikasi Klinis Stem Cell by Dr. Indah Yulianto
 
Heavy Trauma Patient
Heavy Trauma PatientHeavy Trauma Patient
Heavy Trauma Patient
 
Auto immune bulous pemphigoid Case Study
 Auto immune bulous pemphigoid Case Study Auto immune bulous pemphigoid Case Study
Auto immune bulous pemphigoid Case Study
 
Peranan telomer pada proses penuaan & keganasan akibat Distres
Peranan telomer pada proses penuaan & keganasan akibat DistresPeranan telomer pada proses penuaan & keganasan akibat Distres
Peranan telomer pada proses penuaan & keganasan akibat Distres
 
Tribute lecture at Brawijaya Women & Children Hospital
Tribute lecture at Brawijaya Women & Children HospitalTribute lecture at Brawijaya Women & Children Hospital
Tribute lecture at Brawijaya Women & Children Hospital
 
Advances in Cancer Stem Cell Biology
Advances in Cancer Stem Cell BiologyAdvances in Cancer Stem Cell Biology
Advances in Cancer Stem Cell Biology
 
Allogeineic Stem Cell Transplantation for adult acute lymphoblastic leukemia:...
Allogeineic Stem Cell Transplantation for adult acute lymphoblastic leukemia:...Allogeineic Stem Cell Transplantation for adult acute lymphoblastic leukemia:...
Allogeineic Stem Cell Transplantation for adult acute lymphoblastic leukemia:...
 
Sudut Pandang Moral - Immoral Terhadap Sel Punca by Prof. Dr. Soehartono Taa...
Sudut Pandang Moral - Immoral Terhadap Sel Punca  by Prof. Dr. Soehartono Taa...Sudut Pandang Moral - Immoral Terhadap Sel Punca  by Prof. Dr. Soehartono Taa...
Sudut Pandang Moral - Immoral Terhadap Sel Punca by Prof. Dr. Soehartono Taa...
 
Wharton’s jelly mesenchymal stem cells as off the-shelf cellular therapeutics...
Wharton’s jelly mesenchymal stem cells as off the-shelf cellular therapeutics...Wharton’s jelly mesenchymal stem cells as off the-shelf cellular therapeutics...
Wharton’s jelly mesenchymal stem cells as off the-shelf cellular therapeutics...
 
Dermama catalog corporate profile
Dermama   catalog corporate profileDermama   catalog corporate profile
Dermama catalog corporate profile
 
Stem Cell Therapy & Other Recent Advances in Muscular dystrophy
Stem Cell Therapy & Other Recent Advances in Muscular dystrophyStem Cell Therapy & Other Recent Advances in Muscular dystrophy
Stem Cell Therapy & Other Recent Advances in Muscular dystrophy
 
Regenerative medicine 2006
Regenerative medicine 2006Regenerative medicine 2006
Regenerative medicine 2006
 
Treating Options for Acute lymphoblastic Leukemia
Treating Options for Acute lymphoblastic LeukemiaTreating Options for Acute lymphoblastic Leukemia
Treating Options for Acute lymphoblastic Leukemia
 
Conditioned medium – of adipocyte derived stem cells
Conditioned medium – of adipocyte derived stem cellsConditioned medium – of adipocyte derived stem cells
Conditioned medium – of adipocyte derived stem cells
 
Stem sel pada hewan dan aplikasinya
Stem sel pada hewan dan aplikasinyaStem sel pada hewan dan aplikasinya
Stem sel pada hewan dan aplikasinya
 
And iemerg 2014
And iemerg 2014And iemerg 2014
And iemerg 2014
 
Platelets rich plasma for skin rejuvenation
Platelets rich plasma for skin rejuvenationPlatelets rich plasma for skin rejuvenation
Platelets rich plasma for skin rejuvenation
 

Similaire à Dermama faq on stem cells

The ISSCR is an independent, nonprofit organization providin.docx
The ISSCR is an independent, nonprofit organization providin.docxThe ISSCR is an independent, nonprofit organization providin.docx
The ISSCR is an independent, nonprofit organization providin.docxoreo10
 
Stem cells technology and applications
Stem cells technology and applicationsStem cells technology and applications
Stem cells technology and applicationszuharahman2
 
Regenerative Medicine Essay
Regenerative Medicine EssayRegenerative Medicine Essay
Regenerative Medicine EssayAbdulaziz Alanzi
 
Stem cell technology | Presented by pranjali V. Bhadane
Stem cell technology | Presented by pranjali V. BhadaneStem cell technology | Presented by pranjali V. Bhadane
Stem cell technology | Presented by pranjali V. Bhadanepranjali bhadane
 
Stem cells & Regenerative Medicine
Stem cells & Regenerative MedicineStem cells & Regenerative Medicine
Stem cells & Regenerative MedicineDr. Roopam Jain
 
Potential Uses of Stem Cells
Potential Uses of Stem CellsPotential Uses of Stem Cells
Potential Uses of Stem CellsVarun
 
Stem Cells and Stem Cell Therapy.pdf
Stem Cells and Stem Cell Therapy.pdfStem Cells and Stem Cell Therapy.pdf
Stem Cells and Stem Cell Therapy.pdfMercymakiko
 
Stem cells biology and their application in clinical medicine
Stem cells biology and their application in clinical medicineStem cells biology and their application in clinical medicine
Stem cells biology and their application in clinical medicineRajesh Shukla
 
STEmmmmmmmmmmmmmmmmmmmmmmmmmmmmmmmmmm.mmmmmmmmmmmmmmmmM CELL RESEARCH AND THE...
STEmmmmmmmmmmmmmmmmmmmmmmmmmmmmmmmmmm.mmmmmmmmmmmmmmmmM CELL RESEARCH AND THE...STEmmmmmmmmmmmmmmmmmmmmmmmmmmmmmmmmmm.mmmmmmmmmmmmmmmmM CELL RESEARCH AND THE...
STEmmmmmmmmmmmmmmmmmmmmmmmmmmmmmmmmmm.mmmmmmmmmmmmmmmmM CELL RESEARCH AND THE...IbrahemIssacGaied
 
256447 stem-cell-transplantation
256447 stem-cell-transplantation256447 stem-cell-transplantation
256447 stem-cell-transplantationYoAmoNYC
 
256447 stem-cell-transplantation
256447 stem-cell-transplantation256447 stem-cell-transplantation
256447 stem-cell-transplantationabctutor
 

Similaire à Dermama faq on stem cells (20)

The ISSCR is an independent, nonprofit organization providin.docx
The ISSCR is an independent, nonprofit organization providin.docxThe ISSCR is an independent, nonprofit organization providin.docx
The ISSCR is an independent, nonprofit organization providin.docx
 
Stem Cell
Stem CellStem Cell
Stem Cell
 
Stem cells technology and applications
Stem cells technology and applicationsStem cells technology and applications
Stem cells technology and applications
 
Regenerative Medicine Essay
Regenerative Medicine EssayRegenerative Medicine Essay
Regenerative Medicine Essay
 
Stem cell therapy
Stem cell therapyStem cell therapy
Stem cell therapy
 
Stem cell technology | Presented by pranjali V. Bhadane
Stem cell technology | Presented by pranjali V. BhadaneStem cell technology | Presented by pranjali V. Bhadane
Stem cell technology | Presented by pranjali V. Bhadane
 
Stem cells & Regenerative Medicine
Stem cells & Regenerative MedicineStem cells & Regenerative Medicine
Stem cells & Regenerative Medicine
 
Potential Uses of Stem Cells
Potential Uses of Stem CellsPotential Uses of Stem Cells
Potential Uses of Stem Cells
 
Stem cells
Stem cellsStem cells
Stem cells
 
Stem Cells and Stem Cell Therapy.pdf
Stem Cells and Stem Cell Therapy.pdfStem Cells and Stem Cell Therapy.pdf
Stem Cells and Stem Cell Therapy.pdf
 
Lecture stem Cells.pptx
Lecture stem Cells.pptxLecture stem Cells.pptx
Lecture stem Cells.pptx
 
Adult stem cells hope
Adult stem cells hopeAdult stem cells hope
Adult stem cells hope
 
Stem cell culture
Stem cell cultureStem cell culture
Stem cell culture
 
Stem cells biology and their application in clinical medicine
Stem cells biology and their application in clinical medicineStem cells biology and their application in clinical medicine
Stem cells biology and their application in clinical medicine
 
Stem cells
Stem cellsStem cells
Stem cells
 
Stem cells
Stem cellsStem cells
Stem cells
 
Stem cells kl
Stem cells klStem cells kl
Stem cells kl
 
STEmmmmmmmmmmmmmmmmmmmmmmmmmmmmmmmmmm.mmmmmmmmmmmmmmmmM CELL RESEARCH AND THE...
STEmmmmmmmmmmmmmmmmmmmmmmmmmmmmmmmmmm.mmmmmmmmmmmmmmmmM CELL RESEARCH AND THE...STEmmmmmmmmmmmmmmmmmmmmmmmmmmmmmmmmmm.mmmmmmmmmmmmmmmmM CELL RESEARCH AND THE...
STEmmmmmmmmmmmmmmmmmmmmmmmmmmmmmmmmmm.mmmmmmmmmmmmmmmmM CELL RESEARCH AND THE...
 
256447 stem-cell-transplantation
256447 stem-cell-transplantation256447 stem-cell-transplantation
256447 stem-cell-transplantation
 
256447 stem-cell-transplantation
256447 stem-cell-transplantation256447 stem-cell-transplantation
256447 stem-cell-transplantation
 

Dernier

MS Copilot expands with MS Graph connectors
MS Copilot expands with MS Graph connectorsMS Copilot expands with MS Graph connectors
MS Copilot expands with MS Graph connectorsNanddeep Nachan
 
Automating Google Workspace (GWS) & more with Apps Script
Automating Google Workspace (GWS) & more with Apps ScriptAutomating Google Workspace (GWS) & more with Apps Script
Automating Google Workspace (GWS) & more with Apps Scriptwesley chun
 
Apidays New York 2024 - The value of a flexible API Management solution for O...
Apidays New York 2024 - The value of a flexible API Management solution for O...Apidays New York 2024 - The value of a flexible API Management solution for O...
Apidays New York 2024 - The value of a flexible API Management solution for O...apidays
 
Apidays New York 2024 - Scaling API-first by Ian Reasor and Radu Cotescu, Adobe
Apidays New York 2024 - Scaling API-first by Ian Reasor and Radu Cotescu, AdobeApidays New York 2024 - Scaling API-first by Ian Reasor and Radu Cotescu, Adobe
Apidays New York 2024 - Scaling API-first by Ian Reasor and Radu Cotescu, Adobeapidays
 
AXA XL - Insurer Innovation Award Americas 2024
AXA XL - Insurer Innovation Award Americas 2024AXA XL - Insurer Innovation Award Americas 2024
AXA XL - Insurer Innovation Award Americas 2024The Digital Insurer
 
Apidays Singapore 2024 - Building Digital Trust in a Digital Economy by Veron...
Apidays Singapore 2024 - Building Digital Trust in a Digital Economy by Veron...Apidays Singapore 2024 - Building Digital Trust in a Digital Economy by Veron...
Apidays Singapore 2024 - Building Digital Trust in a Digital Economy by Veron...apidays
 
Apidays New York 2024 - The Good, the Bad and the Governed by David O'Neill, ...
Apidays New York 2024 - The Good, the Bad and the Governed by David O'Neill, ...Apidays New York 2024 - The Good, the Bad and the Governed by David O'Neill, ...
Apidays New York 2024 - The Good, the Bad and the Governed by David O'Neill, ...apidays
 
Ransomware_Q4_2023. The report. [EN].pdf
Ransomware_Q4_2023. The report. [EN].pdfRansomware_Q4_2023. The report. [EN].pdf
Ransomware_Q4_2023. The report. [EN].pdfOverkill Security
 
GenAI Risks & Security Meetup 01052024.pdf
GenAI Risks & Security Meetup 01052024.pdfGenAI Risks & Security Meetup 01052024.pdf
GenAI Risks & Security Meetup 01052024.pdflior mazor
 
FWD Group - Insurer Innovation Award 2024
FWD Group - Insurer Innovation Award 2024FWD Group - Insurer Innovation Award 2024
FWD Group - Insurer Innovation Award 2024The Digital Insurer
 
Exploring the Future Potential of AI-Enabled Smartphone Processors
Exploring the Future Potential of AI-Enabled Smartphone ProcessorsExploring the Future Potential of AI-Enabled Smartphone Processors
Exploring the Future Potential of AI-Enabled Smartphone Processorsdebabhi2
 
Powerful Google developer tools for immediate impact! (2023-24 C)
Powerful Google developer tools for immediate impact! (2023-24 C)Powerful Google developer tools for immediate impact! (2023-24 C)
Powerful Google developer tools for immediate impact! (2023-24 C)wesley chun
 
2024: Domino Containers - The Next Step. News from the Domino Container commu...
2024: Domino Containers - The Next Step. News from the Domino Container commu...2024: Domino Containers - The Next Step. News from the Domino Container commu...
2024: Domino Containers - The Next Step. News from the Domino Container commu...Martijn de Jong
 
TrustArc Webinar - Stay Ahead of US State Data Privacy Law Developments
TrustArc Webinar - Stay Ahead of US State Data Privacy Law DevelopmentsTrustArc Webinar - Stay Ahead of US State Data Privacy Law Developments
TrustArc Webinar - Stay Ahead of US State Data Privacy Law DevelopmentsTrustArc
 
Architecting Cloud Native Applications
Architecting Cloud Native ApplicationsArchitecting Cloud Native Applications
Architecting Cloud Native ApplicationsWSO2
 
DBX First Quarter 2024 Investor Presentation
DBX First Quarter 2024 Investor PresentationDBX First Quarter 2024 Investor Presentation
DBX First Quarter 2024 Investor PresentationDropbox
 
Artificial Intelligence Chap.5 : Uncertainty
Artificial Intelligence Chap.5 : UncertaintyArtificial Intelligence Chap.5 : Uncertainty
Artificial Intelligence Chap.5 : UncertaintyKhushali Kathiriya
 
ProductAnonymous-April2024-WinProductDiscovery-MelissaKlemke
ProductAnonymous-April2024-WinProductDiscovery-MelissaKlemkeProductAnonymous-April2024-WinProductDiscovery-MelissaKlemke
ProductAnonymous-April2024-WinProductDiscovery-MelissaKlemkeProduct Anonymous
 
Connector Corner: Accelerate revenue generation using UiPath API-centric busi...
Connector Corner: Accelerate revenue generation using UiPath API-centric busi...Connector Corner: Accelerate revenue generation using UiPath API-centric busi...
Connector Corner: Accelerate revenue generation using UiPath API-centric busi...DianaGray10
 
A Year of the Servo Reboot: Where Are We Now?
A Year of the Servo Reboot: Where Are We Now?A Year of the Servo Reboot: Where Are We Now?
A Year of the Servo Reboot: Where Are We Now?Igalia
 

Dernier (20)

MS Copilot expands with MS Graph connectors
MS Copilot expands with MS Graph connectorsMS Copilot expands with MS Graph connectors
MS Copilot expands with MS Graph connectors
 
Automating Google Workspace (GWS) & more with Apps Script
Automating Google Workspace (GWS) & more with Apps ScriptAutomating Google Workspace (GWS) & more with Apps Script
Automating Google Workspace (GWS) & more with Apps Script
 
Apidays New York 2024 - The value of a flexible API Management solution for O...
Apidays New York 2024 - The value of a flexible API Management solution for O...Apidays New York 2024 - The value of a flexible API Management solution for O...
Apidays New York 2024 - The value of a flexible API Management solution for O...
 
Apidays New York 2024 - Scaling API-first by Ian Reasor and Radu Cotescu, Adobe
Apidays New York 2024 - Scaling API-first by Ian Reasor and Radu Cotescu, AdobeApidays New York 2024 - Scaling API-first by Ian Reasor and Radu Cotescu, Adobe
Apidays New York 2024 - Scaling API-first by Ian Reasor and Radu Cotescu, Adobe
 
AXA XL - Insurer Innovation Award Americas 2024
AXA XL - Insurer Innovation Award Americas 2024AXA XL - Insurer Innovation Award Americas 2024
AXA XL - Insurer Innovation Award Americas 2024
 
Apidays Singapore 2024 - Building Digital Trust in a Digital Economy by Veron...
Apidays Singapore 2024 - Building Digital Trust in a Digital Economy by Veron...Apidays Singapore 2024 - Building Digital Trust in a Digital Economy by Veron...
Apidays Singapore 2024 - Building Digital Trust in a Digital Economy by Veron...
 
Apidays New York 2024 - The Good, the Bad and the Governed by David O'Neill, ...
Apidays New York 2024 - The Good, the Bad and the Governed by David O'Neill, ...Apidays New York 2024 - The Good, the Bad and the Governed by David O'Neill, ...
Apidays New York 2024 - The Good, the Bad and the Governed by David O'Neill, ...
 
Ransomware_Q4_2023. The report. [EN].pdf
Ransomware_Q4_2023. The report. [EN].pdfRansomware_Q4_2023. The report. [EN].pdf
Ransomware_Q4_2023. The report. [EN].pdf
 
GenAI Risks & Security Meetup 01052024.pdf
GenAI Risks & Security Meetup 01052024.pdfGenAI Risks & Security Meetup 01052024.pdf
GenAI Risks & Security Meetup 01052024.pdf
 
FWD Group - Insurer Innovation Award 2024
FWD Group - Insurer Innovation Award 2024FWD Group - Insurer Innovation Award 2024
FWD Group - Insurer Innovation Award 2024
 
Exploring the Future Potential of AI-Enabled Smartphone Processors
Exploring the Future Potential of AI-Enabled Smartphone ProcessorsExploring the Future Potential of AI-Enabled Smartphone Processors
Exploring the Future Potential of AI-Enabled Smartphone Processors
 
Powerful Google developer tools for immediate impact! (2023-24 C)
Powerful Google developer tools for immediate impact! (2023-24 C)Powerful Google developer tools for immediate impact! (2023-24 C)
Powerful Google developer tools for immediate impact! (2023-24 C)
 
2024: Domino Containers - The Next Step. News from the Domino Container commu...
2024: Domino Containers - The Next Step. News from the Domino Container commu...2024: Domino Containers - The Next Step. News from the Domino Container commu...
2024: Domino Containers - The Next Step. News from the Domino Container commu...
 
TrustArc Webinar - Stay Ahead of US State Data Privacy Law Developments
TrustArc Webinar - Stay Ahead of US State Data Privacy Law DevelopmentsTrustArc Webinar - Stay Ahead of US State Data Privacy Law Developments
TrustArc Webinar - Stay Ahead of US State Data Privacy Law Developments
 
Architecting Cloud Native Applications
Architecting Cloud Native ApplicationsArchitecting Cloud Native Applications
Architecting Cloud Native Applications
 
DBX First Quarter 2024 Investor Presentation
DBX First Quarter 2024 Investor PresentationDBX First Quarter 2024 Investor Presentation
DBX First Quarter 2024 Investor Presentation
 
Artificial Intelligence Chap.5 : Uncertainty
Artificial Intelligence Chap.5 : UncertaintyArtificial Intelligence Chap.5 : Uncertainty
Artificial Intelligence Chap.5 : Uncertainty
 
ProductAnonymous-April2024-WinProductDiscovery-MelissaKlemke
ProductAnonymous-April2024-WinProductDiscovery-MelissaKlemkeProductAnonymous-April2024-WinProductDiscovery-MelissaKlemke
ProductAnonymous-April2024-WinProductDiscovery-MelissaKlemke
 
Connector Corner: Accelerate revenue generation using UiPath API-centric busi...
Connector Corner: Accelerate revenue generation using UiPath API-centric busi...Connector Corner: Accelerate revenue generation using UiPath API-centric busi...
Connector Corner: Accelerate revenue generation using UiPath API-centric busi...
 
A Year of the Servo Reboot: Where Are We Now?
A Year of the Servo Reboot: Where Are We Now?A Year of the Servo Reboot: Where Are We Now?
A Year of the Servo Reboot: Where Are We Now?
 

Dermama faq on stem cells

  • 1. FREQUENTLY ASKED QUESTIONS INFORMATION ON STEM CELLS FOR GENERAL AUDIENCE
  • 2. WHAT IS STEM CELLS? Stem cells are the foundation cells for every organ and tissue in our bodies. The highly specialized cells that make up these tissues originally came from an initial pool of stem cells formed shortly after fertilization. Cell Life. Throughout our lives, we continue to rely on stem cells to replace injured tissues and cells that are lost every day, such as those in our skin, hair, blood and the lining of our gut. Properties. Stem cells have two key properties: 1) the ability to self-renew, dividing in a way that makes copies of themselves, and 2) the ability to differentiate, giving rise to the mature types of cells that make up our organs and tissues
  • 3. STEM CELLS TYPE 1. Embryonic Stem Cells Cells derived from very early in development, usually the inner cell mass of a developing blastocyst (very early embrio). These cells are self-renewing (can replicate themselves) and pluripotent (can form all cell types found in the body). 2. Fetal Stem Cells fetal stem cells are taken from the fetus. The developing baby is referred to as a fetus from approximately 10 weeks of gestation. Most tissues in a fetus contain stem cells that drive the rapid growth and development of the organs. Like adult stem cells, fetal stem cells are generally tissue specific, and generate the mature cell types within the particular tissue or organ in which they are found. 3. Cord Blood Stem Cells At birth the blood in the umbilical cord is rich in blood-forming stem cells. The applications of cord blood are similar to those of adult bone marrow and are currently used to treat diseases and conditions of the blood or to restore the blood system after treatment for specific cancers. Like the stem cells in adult bone marrow, cord blood stem cells are tissue-specific.
  • 4. STEM CELLS TYPE 4. Adult Stem Cells or Tissue Specific Stem Cells Stem cells found in different tissues of the body that can give rise to some or all of the mature cell types found within the particular tissue or organ from which they came, i.e., blood stem cells can give rise to all the cells that make up the blood, but not the cells of organs such as the liver or brain. 5. Mesenchymal Stem Cells Mesenchymal stem cells were originally discovered in the bone marrow, but have since been found throughout the body and can give rise to a large number of connective tissue types such as bone, cartilage and fat. 6. Induced Pluripotent Stem Cells (iPS cells) stem cells that were from a cell with a specialized function (for example, a skin cell) that has been “reprogrammed” to an unspecialized state similar to that of an embryonic stem cell.
  • 5. WHAT IS STEM CELLS THERAPY Therapy. A stem cell therapy is a treatment that uses: – Stem cells, – Protein secreted by stem cells , or – Cells that come from stem cells, to replace or to repair a patient’s cells or tissues that are damaged. Application. The stem cells might be put into the blood, or transplanted into the damaged tissue directly, or even recruited from the patient’s own tissues for self-repair.
  • 6. MEDICAL CLINIC Clinical translation is the process used to turn scientific knowledge into real world medical treatments. Researchers take what they have learned about how a tissue usually works and what goes wrong in a particular disease or injury and use this information to develop new ways to diagnose, stop or fix what goes wrong. Before being marketed or adopted as standard of care, most treatments are tested through clinical trials. Sometimes, in attempting new surgical techniques or where the disease or condition is rare and does not have a large enough group of people to form a clinical trial, certain treatments might be tried on one or two people, a form of testing sometimes referred to as innovative medicine.
  • 7. POTENTIAL THERAPY Blood stem cells are currently the most frequently used stem cells for therapy. For more than 50 years, doctors have been using bone marrow transplants to transfer blood stem cells to patients, and more advanced techniques for collecting blood stem cells are now being used to treat leukemia, lymphoma and several inherited blood disorders. Umbilical cord blood, like bone marrow, is often collected as a source of blood stem cells and in certain cases is being used as an alternative to bone marrow transplantation. Additionally, some bone, skin and corneal diseases or injuries can be treated by grafting tissues that are derived from or maintained by stem cells. These therapies have also been shown to be safe and effective. Mesenchymal stem cell, found throughout the body including in the bone marrow, can be directed to become bone, cartilage, fat and possibly even muscle. In certain experimental models, these cells also have some ability to modify immune functions. These abilities have created considerable interest in developing ways of using mesenchymal stem cells to treat a range of musculoskeletal abnormalities, cardiac disease and some immune abnormalities such as graft-versus-host disease following bone marrow transplant.
  • 8. CHALLENGES First, identifying, isolating and growing the right kind of stem cell, particularly in the case of rare adult stem cells, are painstaking and difficult processes. Pluripotent stem cells, such as embryonic stem cells, can be grown indefinitely in the lab and have the advantage of having the potential to become any cell in the body, but these processes are again very complex and must be tightly controlled. iPS cells, while promising, are also limited by these concerns. In both cases, considerable work remains to be done to ensure that these cells can be isolated and used safely and routinely. Second, as with organ transplants, it is very important to have a close match between the donor tissue and the recipient. The more closely the tissue matches the recipient, the lower the risk of rejection. Being able to avoid the lifelong use of immunosuppressants would also be preferable. The discovery of iPS cells has opened the door to developing patient-specific pluripotent stem cell lines that can later be developed into a needed cell type without the problems of rejection and immunosuppression that occur from transplants from unrelated donors. Third, a system for delivering the cells to the right part of the body must be developed. Once in the right location, the new cells must then be encouraged to integrate and function together with the body’s other cells.